Physician

Wajahat Hussain Khan, M.D.

According to 2025 Medicare claims, Wajahat Khan, M.D. (NPI: 1932426905) practices sleep medicine in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Ocean, NJ. This provider's primary affiliated billing organization is RWJBH OBSERVATION ASSOCIATES LLC (NPI: 1760095806; TIN: 852166597) and primary practice location at 08755-6423. Khan is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 519 traditional Medicare patients, billed 927 HCPCS/CPT codes, and received $126,103 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 15 prescription claims totaling $1,687 in drug costs. DME data shows 1,174 claims. Open Payments data shows 11 records totaling $243. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $18,401 to $1,687. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $15,077 and ending at $47,511.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	625	1,428	$151,690
2016	575	1,398	$146,913
2017	507	1,116	$117,102
2018	567	1,161	$132,028
2019	351	703	$83,630
2020	371	738	$116,336
2021	337	760	$115,380
2022	419	824	$109,749
2023	539	1,098	$147,147
2024	519	927	$126,103

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	39	115	$18,401
2016	39	153	$39,345
2017	38	267	$73,321
2018	22	208	$50,760
2019	15	70	$24,425
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	31	$2,465
2023	N/R	27	$10,403
2024	N/R	15	$1,687

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	175	$9,393
2016	56	327	$13,173
2017	153	606	$20,543
2018	136	454	$15,322
2019	82	285	$8,904
2020	N/R	131	$5,240
2021	130	317	$11,513
2022	318	731	$26,918
2023	445	918	$37,664
2024	477	1,174	$47,428

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	328	543	$168
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	50	56	$102
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	147	178	$97
36556	Insertion of non-tunneled central venous tube for infusion (5 years or older)	27	27	$69
95800	Sleep study including heart rate, breathing, and sleep time	33	33	$31

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7031	Face mask interface, replacement for full face mask, each	N	43	108	$9,508
A7030	Full face mask used with positive airway pressure device, each	N	41	112	$8,776
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	71	175	$5,923
E0601	Continuous positive airway pressure (cpap) device	Y	31	214	$5,825
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	39	90	$4,131

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$243	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Wajahat Hussain Khan, M.D.?

Tedicare shows public-source Medicare data for Wajahat Hussain Khan, M.D. (NPI 1932426905), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wajahat Hussain Khan, M.D. have ACO affiliation data?

Wajahat Hussain Khan, M.D. is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Wajahat Hussain Khan, M.D.?

Wajahat Hussain Khan, M.D. is linked to RWJBH OBSERVATION ASSOCIATES LLC (billing NPI 1760095806) in the available physician profile data.

Does Wajahat Hussain Khan, M.D. have Open Payments data?

Wajahat Hussain Khan, M.D. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.